These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 38942123)
1. Co-occurring conditions during pregnancy and hospitalizations in the first year postpartum among persons with opioid use disorder. Frankeberger J; Coulter RWS; Jarlenski M; Krans EE; Mair C Prev Med; 2024 Aug; 185():108057. PubMed ID: 38942123 [TBL] [Abstract][Full Text] [Related]
2. Opioid-related hospitalizations in Pennsylvania: A latent class analysis. Liu SJ; Mair C; Songer TJ; Krans EE; Wahed A; Talbott E Drug Alcohol Depend; 2019 Sep; 202():185-190. PubMed ID: 31352309 [TBL] [Abstract][Full Text] [Related]
3. Polysubstance use and association with opioid use disorder treatment in the US Veterans Health Administration. Lin LA; Bohnert ASB; Blow FC; Gordon AJ; Ignacio RV; Kim HM; Ilgen MA Addiction; 2021 Jan; 116(1):96-104. PubMed ID: 32428386 [TBL] [Abstract][Full Text] [Related]
4. The impact of Medicaid expansion on postpartum health care utilization among pregnant women with opioid use disorder. Patton BP; Krans EE; Kim JY; Jarlenski M Subst Abus; 2019; 40(3):371-377. PubMed ID: 30908175 [No Abstract] [Full Text] [Related]
5. Association of polysubstance use disorder with treatment quality among Medicaid beneficiaries with opioid use disorder. Smart R; Kim JY; Kennedy S; Tang L; Allen L; Crane D; Mack A; Mohamoud S; Pauly N; Perez R; Donohue J J Subst Abuse Treat; 2023 Jan; 144():108921. PubMed ID: 36327615 [TBL] [Abstract][Full Text] [Related]
6. Prevalence of comorbid substance use disorders among people with opioid use disorder: A systematic review & meta-analysis. Santo T; Gisev N; Campbell G; Colledge-Frisby S; Wilson J; Tran LT; Lynch M; Martino-Burke D; Taylor S; Degenhardt L Int J Drug Policy; 2024 Jun; 128():104434. PubMed ID: 38677160 [TBL] [Abstract][Full Text] [Related]
7. Association of Comorbid Behavioral and Medical Conditions With Cannabis Use Disorder in Pregnancy. Meinhofer A; Hinde JM; Keyes KM; Lugo-Candelas C JAMA Psychiatry; 2022 Jan; 79(1):50-58. PubMed ID: 34730782 [TBL] [Abstract][Full Text] [Related]
8. Incidence of hospitalization for postpartum psychotic and bipolar episodes in women with and without prior prepregnancy or prenatal psychiatric hospitalizations. Harlow BL; Vitonis AF; Sparen P; Cnattingius S; Joffe H; Hultman CM Arch Gen Psychiatry; 2007 Jan; 64(1):42-8. PubMed ID: 17199053 [TBL] [Abstract][Full Text] [Related]
9. Investigating the association between metabolic syndrome conditions and perinatal mental illness: a national administrative claims study. Chhabria K; Selvaraj S; Refuerzo J; Truong C; Cazaban CG BMC Pregnancy Childbirth; 2024 Jun; 24(1):409. PubMed ID: 38849738 [TBL] [Abstract][Full Text] [Related]
10. Polysubstance Use Among Pregnant Women With Opioid Use Disorder in the United States, 2007-2016. Jarlenski MP; Paul NC; Krans EE Obstet Gynecol; 2020 Sep; 136(3):556-564. PubMed ID: 32769641 [TBL] [Abstract][Full Text] [Related]
11. Chronic pain among patients with opioid use disorder: Results from electronic health records data. Hser YI; Mooney LJ; Saxon AJ; Miotto K; Bell DS; Huang D J Subst Abuse Treat; 2017 Jun; 77():26-30. PubMed ID: 28476267 [TBL] [Abstract][Full Text] [Related]
12. Contraceptive initiation after delivery among women with and without opioid use disorders: A retrospective cohort study in a statewide Medicaid population, 2005-2016. Charron E; Rennert L; Mayo RM; Eichelberger KY; Dickes L; Truong KD Drug Alcohol Depend; 2021 Mar; 220():108533. PubMed ID: 33513446 [TBL] [Abstract][Full Text] [Related]
13. Predictors of comorbid polysubstance use and mental health disorders in young adults-a latent class analysis. Salom CL; Betts KS; Williams GM; Najman JM; Alati R Addiction; 2016 Jan; 111(1):156-64. PubMed ID: 26190689 [TBL] [Abstract][Full Text] [Related]
15. Comparative Effectiveness Associated With Buprenorphine and Naltrexone in Opioid Use Disorder and Cooccurring Polysubstance Use. Xu KY; Mintz CM; Presnall N; Bierut LJ; Grucza RA JAMA Netw Open; 2022 May; 5(5):e2211363. PubMed ID: 35536575 [TBL] [Abstract][Full Text] [Related]
16. Mental health and substance use disorder comorbidities among Medicaid beneficiaries: Associations with opioid use disorder and prescription opioid misuse. Swartz JA; Franceschini D; Scamperle K AIMS Public Health; 2023; 10(3):658-677. PubMed ID: 37842281 [TBL] [Abstract][Full Text] [Related]
17. Adverse events among adult Medicaid enrollees with opioid use disorder and co-occurring substance use disorders. O'Brien P; Henke RM; Schaefer MB; Lin J; Creedon TB Drug Alcohol Depend; 2021 Apr; 221():108555. PubMed ID: 33596496 [TBL] [Abstract][Full Text] [Related]
18. Pregnant women with opioid use disorder and their infants in three state Medicaid programs in 2013-2016. Clemans-Cope L; Lynch V; Howell E; Hill I; Holla N; Morgan J; Johnson P; Cross-Barnet C; Thompson JA Drug Alcohol Depend; 2019 Feb; 195():156-163. PubMed ID: 30677745 [TBL] [Abstract][Full Text] [Related]
19. Co-occurring substance use and mental disorders among adults with opioid use disorder. Jones CM; McCance-Katz EF Drug Alcohol Depend; 2019 Apr; 197():78-82. PubMed ID: 30784952 [TBL] [Abstract][Full Text] [Related]
20. Polysubstance Use, Mood Disorders, and Chronic Conditions With Anxiety in Opioid Patients. Liu S; Nwabueze C; Pan Y; Walter SM; Su B; Xu C; Winstanley EL; Wang K West J Nurs Res; 2022 Dec; 44(12):1088-1099. PubMed ID: 34301163 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]